Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain

ClinicalTrials.gov ID: NCT00661635

Public ClinicalTrials.gov record NCT00661635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 5:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for Treatment of Post-Surgical Pain From Laparoscopic Cholecystectomy Surgery

Study identification

NCT ID
NCT00661635
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
490 participants

Conditions and interventions

Interventions

  • placebo Drug
  • valdecoxib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2002
Primary completion
Not listed
Completion
Jun 30, 2003
Last update posted
Apr 22, 2008

2002 – 2003

United States locations

U.S. sites
65
U.S. states
20
U.S. cities
50
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35213
Pfizer Investigational Site Daphne Alabama 36526
Pfizer Investigational Site Fairhope Alabama 36532
Pfizer Investigational Site Mobile Alabama 36617
Pfizer Investigational Site Mobile Alabama 36693
Pfizer Investigational Site Sheffield Alabama 35660
Pfizer Investigational Site Glendale Arizona 85306
Pfizer Investigational Site Glendale Arizona 85308
Pfizer Investigational Site Phoenix Arizona 85006
Pfizer Investigational Site Phoenix Arizona 85020
Pfizer Investigational Site Phoenix Arizona 85023
Pfizer Investigational Site Phoenix Arizona 85027
Pfizer Investigational Site Tucson Arizona 85710
Pfizer Investigational Site Tucson Arizona 85711
Pfizer Investigational Site Tucson Arizona 85712
Pfizer Investigational Site Anaheim California 92801
Pfizer Investigational Site Bakersfield California 93309
Pfizer Investigational Site Bakersfield California 93311
Pfizer Investigational Site Los Angeles California 90017
Pfizer Investigational Site Los Angeles California 90057
Pfizer Investigational Site Pasadena California 91109
Pfizer Investigational Site Sacramento California 95817
Pfizer Investigational Site San Jose California 95124
Pfizer Investigational Site Woodland California 95695
Pfizer Investigational Site Miami Florida 33136
Pfizer Investigational Site Miami Florida 33176
Pfizer Investigational Site Pensacola Florida 32504
Pfizer Investigational Site Blue Ridge Georgia 30513
Pfizer Investigational Site Marietta Georgia 30060
Pfizer Investigational Site Chicago Illinois 60611
Pfizer Investigational Site Maywood Illinois 60153
Pfizer Investigational Site Iowa City Iowa 52242
Pfizer Investigational Site Shreveport Louisiana 71105
Pfizer Investigational Site Baltimore Maryland 21229
Pfizer Investigational Site Germantown Maryland 20874
Pfizer Investigational Site Rockville Maryland 20850
Pfizer Investigational Site Silver Spring Maryland 20902
Pfizer Investigational Site Jackson Mississippi 39202
Pfizer Investigational Site Durham North Carolina 27710
Pfizer Investigational Site Winston-Salem North Carolina 27103-3315
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Oklahoma City Oklahoma 73104
Pfizer Investigational Site Allentown Pennsylvania 18103
Pfizer Investigational Site Philadelphia Pennsylvania 19107-4998
Pfizer Investigational Site Pittsburgh Pennsylvania 15212
Pfizer Investigational Site Charleston South Carolina 29406
Pfizer Investigational Site Columbia South Carolina 29203
Pfizer Investigational Site Columbia South Carolina 29209
Pfizer Investigational Site Mt. Pleasant South Carolina 29464
Pfizer Investigational Site North Charleston South Carolina 29406
Pfizer Investigational Site Summerville South Carolina 29485
Pfizer Investigational Site Bristol Tennessee 37620
Pfizer Investigational Site Kingsport Tennessee 37660
Pfizer Investigational Site Houston Texas 77024
Pfizer Investigational Site Houston Texas 77055
Pfizer Investigational Site San Antonio Texas 78224
Pfizer Investigational Site Universal City Texas 78148
Pfizer Investigational Site Sandy City Utah 84070
Pfizer Investigational Site Sandy City Utah 84094
Pfizer Investigational Site West Jordan Utah 84088
Pfizer Investigational Site Norfolk Virginia 23517
Pfizer Investigational Site Suffolk Virginia 23434
Pfizer Investigational Site Renton Washington 98055
Pfizer Investigational Site Renton Washington 98058-5010
Pfizer Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00661635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2008 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00661635 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →